Metsera accepts Pfizer's $10 billion bid in ongoing M&A battle
Pfizer said it would pay $86.25 per share in cash, a premium of 3.69% to Metsera's Friday close.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.